MedX Health Dirección

Dirección controles de criterios 2/4

El CEO de MedX Health's es Stephen Lockyer, nombrado en May 2023, tiene una permanencia de menos de un año. posee directamente un 9.44% de las acciones de la empresa, con un valor de CA$2.47M. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 5.9 años, respectivamente.

Información clave

Stephen Lockyer

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	9.4%
Permanencia media de la dirección	2.9yrs
Promedio de permanencia en la Junta Directiva	6yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Stephen Lockyer

less than a year

Permanencia

Mr. Stephen Lockyer serves as Director of MedX Health Corp since April 12, 2023 and serves as its Chief Executive Officer since May 11, 2023. He co founded Cornwallis Financial Corporation and serves as it...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Christopher Freeman	Corporate Secretary & Acting CFO	2.1yrs	CA$14.93k	sin datos
Michael Druhan	President of Dermatological Services & Products	3.7yrs	CA$273.52k	sin datos
Stephen Lockyer	CEO & Director	less than a year	sin datos	9.44% CA$ 2.1m
Scott Naughton	Managing Director of US Operations	7.4yrs	sin datos	sin datos

2.9yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de MDX se considera experimentado (2.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Stephen Lockyer	CEO & Director	1.1yrs	sin datos	9.44% CA$ 2.1m
David Henniger	Independent Vice Chairman	22.5yrs	sin datos	1.36% CA$ 302.0k
Kenneth McKay	Independent Chairman	22.5yrs	sin datos	0.33% CA$ 73.8k
Daniel Siegel	Member of Medical Advisory Board	6yrs	sin datos	sin datos
Dennis Reich	Member of Medical Advisory Board	7.3yrs	sin datos	sin datos
Trevor Champagne	Chairman of Medical Advisory Board	5.8yrs	sin datos	sin datos
Joe Walls	Member of Medical Advisory Board	no data	sin datos	sin datos
Per Hall	Member of Medical Advisory Board	no data	sin datos	sin datos
Edmund Ho	Independent Director	1.1yrs	sin datos	4.67% CA$ 1.0m

6.0yrs

Permanencia media

72yo

Promedio de edad

Junta con experiencia: La junta directiva de MDX se considera experimentada (5.9 años de antigüedad promedio).

MedX Health Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Full year 2023 earnings released: CA$0.023 loss per share (vs CA$0.028 loss in FY 2022)

MedX Health Corp announced that it expects to receive CAD 2 million in funding

New major risk - Share price stability

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.006 loss in 3Q 2022)

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp announced that it has received CAD 1.02 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2022)

New major risk - Share price stability

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 1Q 2022)

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

Full year 2022 earnings released: CA$0.028 loss per share (vs CA$0.03 loss in FY 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Third quarter 2022 earnings released: CA$0.006 loss per share (vs CA$0.009 loss in 3Q 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2021)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Full year 2021 earnings released: CA$0.03 loss per share (vs CA$0.019 loss in FY 2020)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Chairman of the Board Robert von der Porten has left the company

Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2020)

COO & MD of Light Therapy Products recently sold CA$53k worth of stock

First quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 1Q 2020)

MedX Health Corp announced that it expects to receive CAD 2.5 million in funding

Full year 2020 earnings released: CA$0.019 loss per share (vs CA$0.023 loss in FY 2019)

MedX Health Corp. Announces Retirement of Board Members

EMPOWER CLINICS INC. and MedX Health Corporation Announce Memorandum of Understanding to Pilot MedX's Leading-Edge DermSecure Screening Platform At Two Select Empower Clinics Locations in Ontario

MedX Health Corp. Announces the Appointment of Paul Karam as Sales and Marketing Director for Europe, Middle East, Africa (EMEA)

New 90-day high: CA$0.24

MedX Health Corp announced that it expects to receive CAD 4 million in funding

MedX Health Corporation Appoints Trevor Champagne as Chair Medical Advisory Board

Medx Health Corp. Announces the Rollout of DermSecure in the Netherlands

Third quarter 2020 earnings released: CA$0.006 loss per share

MedX Health Corp Announces Board Changes

Medx Health Corp. Appoints Anthony Milonas and Wayne Cockburn as Directors

First half earnings released

MedX Health Corp. Announces Management Appointments

MedX Health Corp announced that it expects to receive CAD 2 million in funding

CEO

Permanencia

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media

Promedio de edad